1Hashim M,Sayed M,Samy N,et al.Prognostic significance of telomerase activity and some tumor markers in non-small cell lung cancer[J].Med Oncol,2010,39:309-316.
2Molina R,Filella X,Auge JM,et al.Tumor markers (CEA,CA125,CYFRA 21-1,SCC and NSE) in patients with non-small cell lung cancer as an aid in histological diagnosis and prognosis.Comparison with the main clinical and pathological prognostic factors[J].Tumour Biol,2003,24 (4):209-218.
3Shitrit D,Zingerman B,Shitrit AB,et al.Diagnostic value of CYFRA21-1,CEA,CA19-9,CA15-3,and CA125 assays in pleural effusions:analysis of 116 cases and review of the literature[J].Oncologist,2005,10(7):501-507.
5Vincent RG,Chu-TM,Lane-WW.The value of CEA in patients with carcinoma of the lung.Cancer,1979,44:685
6尹伯元主编.放射免疫分析在医学中的应用.北京:原子能出版社,1991,328-331
7Muraki M,Tohda Y,Iwanaga T,et al.Assessment of serum CYFRA21-1 in lung cancer.Cancer,1996,77(7):1274~1277
8Brechot JM,Chevret S,Nataf J,et al.Diagnostic and prognostic value of Cyfra21-1 compared with other tumor markers in patients with non-small cell lung cancer:a prospective study of 116patients.Eur J Cancer,1997,33 (3):385~391
9Lai RS, Chen CC, Lee PC, et al. Evaluation of cytokeration 19 fragment(CYFRA21 - 1 )as a tumor marker in malignant Pleural effusion[ J ]. Jpn J Clin Oncol, 2003,29 (9) : 421 - 423.
10Pujol JL, Boher JM, Grenier J, et al. Cyfra 21-1 neuron specific enolase and prognosis of non-small cell lung caner: prospective study in 621 patients [ J ]. Lung Cancer, 2001,31 ( 2 - 3 ) : 221 - 231.